NM Coordinating Committee: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 2: | Line 2: | ||
Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD | Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD | ||
*[https://tinyurl.com/QIBA-NM-CC-Roster '''Roster'''] | *[https://tinyurl.com/QIBA-NM-CC-Roster '''Roster'''] | ||
Revision as of 18:44, 21 December 2023
Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD
Scope
The NM Coordinating Committee is responsible for:
- Monitoring and coordinating the activities of NM Biomarker Committees
- QIBA Profile Dashboard (NM Page)
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
- FDG-PET_Biomarker_Ctte
- PET_Amyloid_Biomarker_Ctte
- SPECT_Biomarker_Ctte
- TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee]
- I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee]
- PET Myocardial Blood Flow [page: https://qibawiki.rsna.org/index.php/PET_Myocardial_Blood_Flow_Biomarker_Committee]
Meetings
- Zoom calls are held Quarterly. Please contact RSNA Staff for details.